DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

ACACIA

Search structure
Synonyms:
Acacia
Acacia arabica
Acacia circummarginata resin
Acacia cufodontii resin
Acacia mucilage
Acacia oxyosprion resin
Acacia powder
Acacia rupestris resin
Acacia senegal
Acacia senegal gum
Acacia senegal resin
Acacia seyal
Acacia spinosa resin
Acacia, spray-dried
Acacia verek resin
Acacia volkii resin
E-414-
FEMA NO. 2001
Gum acacia
Gum arabic
Gum arabic (acacia senegal)
Gum arabic (acacia seyal)
Gummi arabicum
Gum senegal
INS-414
INS NO.414
Kher resin
Mimosa senegal resin
Rfaudraksha resin
Senegalia senegal resin
Thorny acacia resin
Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: 5C5403N26O

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Metabolic Syndrome 2 D024821 ClinicalTrials
Anemia, Sickle Cell 1 D000755 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108172
FDA SRS 5C5403N26O
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70